Chrysalis Biomedical Advisors

    OverviewSuggest Edit

    Chrysalis Biomedical Advisors is a company that provides strategy consulting services to startups, established businesses, and investors. It specializes in product evaluation, technology assessment, portfolio strategy, and market intelligence areas. The company delivers its services across healthcare, research, and applied genomics areas.
    TypePrivate
    Founded2016
    Websitechrysalisbiomed.com

    Latest Updates

    Employees (est.) (Nov 2020)5
    Cybersecurity ratingBMore

    Key People/Management at Chrysalis Biomedical Advisors

    Colin A. Baron

    Colin A. Baron

    Partner and Managing Director
    Robert D. Cohen

    Robert D. Cohen

    Partner and Managing Director
    Jordan D. Stockton

    Jordan D. Stockton

    Partner and Managing Director
    Show more

    Chrysalis Biomedical Advisors Financials and Metrics

    Summary Metrics

    Founding Date

    2016

    Chrysalis Biomedical Advisors Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    89/100

    SecurityScorecard logo

    Chrysalis Biomedical Advisors Online and Social Media Presence

    Embed Graph

    Chrysalis Biomedical Advisors Frequently Asked Questions

    • When was Chrysalis Biomedical Advisors founded?

      Chrysalis Biomedical Advisors was founded in 2016.

    • Who are Chrysalis Biomedical Advisors key executives?

      Chrysalis Biomedical Advisors's key executives are Colin A. Baron, Robert D. Cohen and Jordan D. Stockton.

    • How many employees does Chrysalis Biomedical Advisors have?

      Chrysalis Biomedical Advisors has 5 employees.

    • Who are Chrysalis Biomedical Advisors competitors?

      Competitors of Chrysalis Biomedical Advisors include Buck Consulting, McKinsey and Lifescience Dynamics.